BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19524427)

  • 1. The immunology of smallpox vaccines.
    Kennedy RB; Ovsyannikova IG; Jacobson RM; Poland GA
    Curr Opin Immunol; 2009 Jun; 21(3):314-20. PubMed ID: 19524427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioterrorism. Smallpox vaccinations: how much protection remains?
    Cohen J
    Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
    [No Abstract]   [Full Text] [Related]  

  • 4. Keeping the memory of smallpox virus.
    Puissant B; Combadière B
    Cell Mol Life Sci; 2006 Oct; 63(19-20):2249-59. PubMed ID: 16964577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
    Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
    Lu B; Yu W; Huang X; Wang H; Liu L; Chen Z
    J Biomed Biotechnol; 2011; 2011():970424. PubMed ID: 21765641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
    Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
    Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smallpox vaccines: targets of protective immunity.
    Moss B
    Immunol Rev; 2011 Jan; 239(1):8-26. PubMed ID: 21198662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
    Meseda CA; Weir JP
    Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
    Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
    Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approach.
    Yu C; Wu Q; Xin J; Yu Q; Ma Z; Xue M; Xu Q; Zheng C
    Microbiol Spectr; 2024 Jun; 12(6):e0046524. PubMed ID: 38700327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
    Kremer M; Suezer Y; Volz A; Frenz T; Majzoub M; Hanschmann KM; Lehmann MH; Kalinke U; Sutter G
    PLoS Pathog; 2012; 8(3):e1002557. PubMed ID: 22396645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poxvirus Vaccines: Past, Present, and Future.
    Jhancy M
    Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of protective T-cell antigens for smallpox vaccines.
    Ando J; Ngo MC; Ando M; Leen A; Rooney CM
    Cytotherapy; 2020 Nov; 22(11):642-652. PubMed ID: 32747299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine.
    Esparza J; Schrick L; Damaso CR; Nitsche A
    Vaccine; 2017 Dec; 35(52):7222-7230. PubMed ID: 29137821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and Vaccination for Smallpox and Monkeypox.
    Saalbach KP
    Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
    Earl PL; Americo JL; Wyatt LS; Espenshade O; Bassler J; Gong K; Lin S; Peters E; Rhodes L; Spano YE; Silvera PM; Moss B
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10889-94. PubMed ID: 18678911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
    Wiser I; Balicer RD; Cohen D
    Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulator-based enhancement of anti smallpox immune responses.
    Martínez O; Miranda E; Ramírez M; Santos S; Rivera C; Vázquez L; Sánchez T; Tremblay RL; Ríos-Olivares E; Otero M
    PLoS One; 2015; 10(4):e0123113. PubMed ID: 25875833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.